Pharmaceutical research and development company Serina Therapeutics has partnered with the Scripps Research Institute to jointly develop polymer-antibody drug conjugates (Polymer-ADCs). Terms and financial details of the deal have not ...
Tags: Polymer-Antibody Drug, Medicine
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...
Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner
Astellas Pharma and Ambrx have collaborated to discover and develop new antibody drug conjugates (ADCs) for the targeted delivery of drugs into cancer tissues. Ambrx will use site-specific conjugation technology in addition to proprietary ...
Tags: Antibody Drug, Health, Medicine
Leica Biosystems and Synthon Biopharmaceuticals have entered into a collaboration agreement to develop and commercialize an automated tissue-based companion diagnostic test for solid tumors. The partnership will leverage Leica BOND ...
Tags: diagnostic test, Biopharmaceuticals, Synthon Biopharmaceuticals
Leica Biosystems and Synthon Biopharmaceuticals have entered into a collaboration agreement to develop and commercialize an automated tissue-based companion diagnostic test for solid tumors. The partnership will leverage Leica BOND ...
Tags: diagnostic test, Biopharmaceuticals, Synthon Biopharmaceuticals
US-based biotechnology company Seattle Genetics has announced that it has gained the Health Canada's Notice of Compliance with conditions (NOC/c) for marketing its ADCETRIS ((Brentuximab Vedotin)) drug used in treating two lymphoma ...
Tags: Seattle Genetics, ADCETRIS drug, Health Canada's Notice of Compliance
Lonza has received a contract from Intellect Neurosciences to develop and manufacture the antibody drug conjugate, Conjumab-A. Under the contract, Lonza will supply the preclinical study material for the drug optimization and drug ...
Tags: Lonza, antibody drug, Neurosciences, antibody drug conjugate
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended conditional approval for Takeda Pharmaceuticals and Millennium adcetris (brentuximab vedotin) in Europe. If the CHMP ...
Tags: CHMP, refractory CD30 positive Hodgkin lymphoma, sALCL
Takeda Pharmaceutical Company and Millennium: The Takeda Oncology Company have won European conditional marketing authorization for Adcetris (brentuximab vedotin). Adcetris is indicated for use in adult patients with relapsed or ...
Tags: adcetris, antibody-drug conjugate, Brentuximab vedotin, sALCL
Sweden based Karolinska Institutet and Immunomedics scientists have collaborated to design and test new class of drugs that destroy the AIDS virus, HIV (Human Immunodeficiency Virus), which may also help in eliminating the virus completely. ...
Tags: Immunomedics, anti-HIV agents, virus
AbD Serotec, MorphoSys' division for research and diagnostic antibodies, is set to introduce a series of the human combinatorial antibody library (HuCAL) anti-drug antibodies supporting the development of novel antibody therapeutics. The ...
Tags: AbD Serotec, HuCAL Anti-Drug Antibodies, antibody therapeutics, MorphoSys
Antibody-drug conjugate (ADC) company, Mersana Therapeutics and Adimab have initiated a joint effort to offer integrated antibody discovery and ADC technologies. The partnership will provide pharmaceutical companies an access to Adimab's ...
Tags: Adimab, Mersana, integrated antibody discovery, ADC technologies